Jasna Pesic
Oncology Institute of Vojvodina(RS)
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Cancer Treatment and Pharmacology, Breast Cancer Treatment Studies, Peptidase Inhibition and Analysis, Advanced Breast Cancer Therapies
Most-Cited Works
- → Male Breast Cancer in the Era of Modern Therapies: Serbian Single Centre Experience Report(2014)2 cited
- → Assessment of enthesitis in patients with psoriasis: Relationships with clinical features, screening questionnaries results, and quality of life: An ultrasound study(2020)1 cited
- → The efficacy of lapatinib in patients with metastatic HER2 positive breast cancer who received prior therapy with monoclonal antibodies and antibody-drug conjugate: a single institutional experience(2021)1 cited
- → Standard therapy of HER2-positive and triple negative metastatic breast cancer - present and future(2013)
- → Steroid aromatase Inhibitors In metastatlc breast cancer after disease progression to nonsterold Inhibitors-efficacy?(2008)
- → Efficacy and tolerability of biweekly paclitaxel combined with cisplatin in the treatment of metastatic breast cancer (MBC) patients previously treated with anthracyclines(2006)
- → Development of distant metastases during adjuvant therapy with trastuzumab (H) in premenopausal patients with HER2-positive breast cancer(2008)
- → Maintaining treatment of locally advanced breast cancer(2003)
- → Factors affecting DFS in triple negative early breast cancer patients – a single institution experience(2008)